Tag: Rubius Therapeutics
Rubius Therapeutics reports $32.6M loss in Q1
SMITHFIELD – Rubius Therapeutics Inc. reported a net loss of $32.6 million in the first quarter of 2019, or 42 cents per diluted share,...
Rubius appoints Holles to board, Whitehead as SVP, chief quality officer
PROVIDENCE – Rubius Therapeutics Inc. has appointed Natalie Holles to its board of directors and Greg Whitehead as senior vice president and chief quality...
Rubius Therapeutics added to Nasdaq biotechnology index
SMITHFIELD – Biotechnology firm Rubius Therapeutics Inc. was added to the Nasdaq biotechnology index on Dec. 24.
The company, based in Cambridge, Mass., but building...
Rubius reports $26.4M loss for Q3
PROVIDENCE – Cambridge, Mass.-headquartered Rubius Therapeutics Inc. announced a $26.4 million net loss for the third quarter of 2018 Tuesday. The company reported an...
Most-read stories on PBN.com, July 2018
1. 2018 40 Under Forty winners feted at Aldrich Mansion POSTED ONLINE: JULY 20. A record crowd of 475 took the occasion of a...
Rubius Therapeutics enters agreement to buy former Alexion site in Smithfield
SMITHFIELD – Rubius Therapeutics Inc., the Cambridge, Mass.-based company recently approved by the R.I. Commerce Corp. for up to $9 million in incentives to...
Rebuild Rhode Island tax credit program surpasses $100M mark
PROVIDENCE – The state’s Rebuild Rhode Island tax credit program recently exceeded the $100 million mark with last month’s award to Rubius Therapeutics Inc.
The...
BBJ: Rubius Therapeutics raises $241M in IPO, highest for biotech company...
PROVIDENCE – Cambridge, Mass.-based Rubius Therapeutics Inc. raised $241 million in its initial public offering Wednesday, the highest for a biotechnology company in Massachusetts...
Most read stories on PBN.com, June 2018
1. 2018 40 under Forty winners chosen
POSTED ONLINE: JUNE 8. Providence Business News has chosen the winners for its 14th 40 Under Forty program,...
Smart incentives help seal deal
Certainly it was good news when Rubius Therapeutics Inc. announced its intention to open a pharmaceutical manufacturing facility in Rhode Island.
It didn’t have to...
- Featured Event -
